ISO-1, a Macrophage Migration Inhibitory Factor Antagonist, Inhibits Airway Remodeling in a Murine Model of Chronic Asthma
Pei‐Fen Chen(Nanfang Hospital), Yousef Al‐Abed(Feinstein Institute for Medical Research), Wei Wang(Capital Medical University), Ya-ling Luo(Nanfang Hospital), Jiangxin Wang(Shenzhen University), Si-Ming Hu(Nanfang Hospital), Wenyan Lai(Nanfang Hospital), Kai Cheng(Chinese Academy of Sciences)
Cited by 56
Related Papers
ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis
|Journal of Biological Chemistry|2005|316
The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents
|Journal of Biological Chemistry|2002|298
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
|Science Immunology|2020|151